Pharma Marketing Network

APRIL 20, 2025

Introduction Is Big Pharma a villainous label or a misunderstood brand? For marketers in 2025, understanding the implications of this term is more important than ever. This article explores the nuances of how this label affects pharmaceutical marketing and what brands can do to respond strategically.

Labelling

PharmExec

AUGUST 1, 2025

New labels will include study summaries, improved dosage warnings, and information on overdose reversal agents to enhance patient and healthcare professional awareness. Label changes aim to promote safer, research-supported decision-making, with a 30-day window for industry recipients to submit updates for review.

Medication Labelling

Pharmacy Times

JUNE 20, 2025

There are too many drug approvals, label updates, and new data published for even the most skilled and experienced oncology pharmacist to keep up with, let alone those still building their baseline knowledge. Accessed May 15, 2025. Accessed May 15, 2025. Accessed May 15, 2025. Accessed May 15, 2025. August 8, 2024.

Compounding

Hospital Pharmacy Europe

APRIL 14, 2025

However, issues arose due to a lack of PAAP, insufficient communication between or within services and families, failure to recognise child deterioration, and treatment delays. Learnings from the CDOPs showed that allergy symptoms were not always communicated to healthcare professionals. Accessed March 2025]. Childhood asthma.

Health and Personal Care Stores

The Nontraditional Pharmacist

JULY 1, 2025

It’s 2025. And ultimately, it’s to ensure we get the data because the data are ultimately what turns into your FDA approved label and demonstrates what you need. So, good talking to you. Matt Paterini (01:21): No, we appreciate the time. And remember, COVID was in there too, right? So, we would have spoken in 2019.

FDA

Viseven

JUNE 18, 2025

Scientific communication : Drafting slide decks, scientific responses, medical information letters, and training content using generative models, ensuring scientific accuracy and compliance in messaging and content. Previously, many organizations, including healthcare companies and facilities, were merely testing the waters.

Labelling

Pharmaceutical Technology

JULY 29, 2025

July 29, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook The therapy is administered subcutaneously once a week, ensuring a sustained release of active, unmodified somatropin. This important milestone is the first of many planned label expansions supporting our goal to become the leading endocrinology rare disease company.”

FDA

Pharmacy Times

JULY 10, 2025

Medication Adherence Requires Personalized Communication Alva emphasized that effective counseling about medications—especially those with intimidating FDA warnings—requires compassionate, patient-centered communication.

Specialty Pharmacies

Pharmacy Times

JULY 15, 2025

Just to share a little bit more about our medication packets: these packets are labeled by date and time, and they come in a monthly pill dispenser box. Lastly, just to touch on health literacy—when you add in our simplified digital communication and educational touch points, you really create space for health literacy as well.

Compounding Pharmacies

Pharmaceutical Technology

JUNE 27, 2025

June 27, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook Label updates have been approved for BMS’ CAR T cell therapies, Breyanzi and Abecma, to treat multiple myeloma. The regulatory agency has also given approval to the removal of the REMS requirement from the product labels.

Labelling

Pharmacy Times

JUNE 5, 2025

Detect-A-Dose lid-label cover enhances medication recognition, reducing packaging errors through a contrasting visual pattern. 1-3 Detect-A-Dose Lid Label Covers. 4 Detect-A-Dose features a contrasting black and white pattern on the underside of its label to make missing doses for patients apparent to pharmacists. REFERENCES 1.

Packaging

PharmExec

AUGUST 1, 2025

The label update refines language and streamlines the safety section by removing certain adverse events, aligning with placebo group occurrence rates. SHOW MORE The updated label no longer requires Leqvio (inclisiran) to be used in combination with statins for low-density lipoprotein cholesterol management.

Labelling

Pharmaceutical Technology

JUNE 23, 2025

Robert Barrie June 23, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook Bayer’s Eylea is a heavyweight of the ophthalmic drug landscape, approved for a range of eye diseases. The biosimilar specialist’s stock has been falling over the past year, though the company did post strong Q1 2025 results earlier this year.

Communication

PharmTech

JUNE 12, 2025

Image Credit: © Tada Images - stock.adobe.com In a June 10, 2025 update, FDA posted seven updated Warning Letters, issued between the beginning of 2025 and the present, to its online database, which stores more than 3400 such letters dating back to 2020 (1). American Behavioral Research Institute Boca Raton, Fla. –

FDA

Pharmaceutical Technology

JULY 7, 2025

July 7, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook Ekterly is intended for treating acute attacks of hereditary angioedema. The positive results from the KONFIDENT trial were further supported by findings from the real-world KONFIDENT-S open-label extension study. Credit: KalVista Pharmaceuticals/Business Wire.

FDA

PharmExec

AUGUST 7, 2025

" Phase II Efficacy and Safety Data The efficacy and safety of Modeyso were evaluated across five open-label, non-randomized Phase II trials: ONC006, ONC013, ONC014, ONC016, and ONC018. August 6, 2025. Accessed August 7, 2025. Accessed August 7, 2025. Accessed August 7, 2025. Clinicaltrials.gov. link] Gliomas.

FDA

Pharmacy Times

JUNE 20, 2025

In general, choosing a product that has broad spectrum on the label, covering both UV-A and UV-B rays and containing 20% zinc oxide, for her children will be optimal, especially for more sensitive areas of the skin. Accessed May 12, 2025. Accessed May 12, 2025. Accessed May 12, 2025. Accessed May 12, 2025.

Compounding Pharmacies

Pharmaceutical Technology

AUGUST 7, 2025

Using real-world data to support vaccine outreach and education Buy Reports Newsletters PT News FDA gives accelerated approval to Jazz Pharma’s diffuse midline glioma therapy Modeyso is expected to be commercially available in late summer 2025. Find out more Modeyso is expected to be commercially available in the late summer of 2025.

FDA

Pharmaceutical Technology

JUNE 18, 2025

June 18, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook The company is studying the therapy in the global Phase IIb PRIZM trial. Subjects who conclude the trial will be qualified for an open-label extension trial. Credit: Volha_R/Shutterstock. Give your business an edge with our leading industry insights.

FDA

Pharmaceutical Commerce

JULY 16, 2025

Existing policies often feature explicit exclusions for non-FDA approved products or harm from off-label use. Maintain unwavering transparency with patients, unequivocally communicating the non-FDA approved status of compounded medications and all associated risks, securing explicit informed consent. May 30, 2025. May 21, 2025.

Compounding

IDStewardship

APRIL 16, 2025

In this article an infectious diseases pharmacist discusses someof many learning tidbitsfrom ESCMID Global 2025, the largest international meeting of clinical microbiologists and infectious diseases specialists. Each bottle was labeled with the data point and the year. Authored By: Timothy P. Gauthier, Pharm.D.,

Labelling

Pharmaceutical Technology

JULY 8, 2025

July 8, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook The collaboration will leverage Chugai’s antibody engineering technologies to create new drug candidates. Sign up for our daily news round-up! Give your business an edge with our leading industry insights. Login Registration is disabled.

Packaging

Pharmaceutical Technology

JULY 8, 2025

July 8, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook The new dose strength for young infants is dissolvable, even in breast milk. Credit: Luma Pimentel/Unsplash. Give your business an edge with our leading industry insights. Thank you for subscribing View all newsletters from across the GlobalData Media network.

Packaging

Pharmaceutical Technology

JUNE 30, 2025

June 30, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook The acquisition will provide Torrent with access to a fast-growing Indian franchise and new therapeutic areas such as ophthalmology. How will RFK Jr’s American dream for vaccines play out? Give your business an edge with our leading industry insights.

Packaging

Pharmaceutical Technology

JULY 15, 2025

July 15, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook Alyftrek is a triple-combination therapy intended for cystic fibrosis. Credit: Jo Panuwat D/Shutterstock. Give your business an edge with our leading industry insights. Thank you for subscribing View all newsletters from across the GlobalData Media network.

Packaging

Pharmaceutical Technology

JULY 15, 2025

July 15, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook The drug is intended for children aged six months and above with homozygous familial hypercholesterolemia. In January 2025, the European Commission (EC) expanded the approval of Evkeeza to include children aged six months to under five years diagnosed with HoFH.

Packaging

Pharmaceutical Technology

JUNE 6, 2025

Robert Barrie June 6, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook NHS England estimates that nearly 2.5 Figures published in May 2025 by NHS England estimated there were nearly 2.5 Originally approved for children in 2021, the FDA updated the drug’s label in January this year to include adults.

Communication

PharmExec

AUGUST 1, 2025

Related Videos Related Content Advertisement August 1st 2025 FDA Mandates Safety Alterations to Opioid Pain Medication Labels Nicholas Jacobus FDA mandates new opioid labeling to highlight long-term risks, aiming to combat addiction and improve patient safety in pain management.

Communication

Pharmaceutical Technology

JUNE 30, 2025

Robert Barrie June 30, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook CAR-Ts, the first of which were initially approved in June 2025, have demonstrated a wealth of efficacy in haematological oncology indications. The agency said that safety information can be adequately conveyed using drug product labelling.

FDA

Pharmaceutical Technology

JULY 14, 2025

Robert Barrie July 14, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook Broader label coverages for Pfizer and Moderna’s vaccines mean they have made in-roads into GSK’s RSV dominant market share. Give your business an edge with our leading industry insights. Login Registration is disabled.

Labelling

PharmExec

AUGUST 6, 2025

August 5, 2025. Sources Trump says pharma tariffs could eventually reach up to 250%. link] Newsletter Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers. Subscribe Now!

Communication

Pharmaceutical Technology

JUNE 30, 2025

Miranda McLaren June 30, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook When Donald Trump was elected the 47 th president of the United States of America, the outlook for pharmaceuticals was unclear, with 55% of North American industry professionals expecting negative repercussions when surveyed by GlobalData later that month.

Health and Personal Care Stores

Pharmaceutical Technology

JUNE 30, 2025

June 30, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook Bird’s-eye view of the current Vetter site in Des Plaines where the clinical manufacturing facility will be built. How will RFK Jr’s American dream for vaccines play out? Give your business an edge with our leading industry insights.

Packaging

Pharmaceutical Technology

JULY 22, 2025

Abigail Beaney July 22, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook Sarepta will pause shipments of the therapy to the US while it discusses the therapy with the FDA. Sarepta confirmed it will work with the FDA to respond to requests for information while advancing the Elevidys safety labelling supplement process.

FDA

Pharmaceutical Technology

JULY 11, 2025

July 11, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook The approval by the EC was based on findings from the RATIONALE-309 trial. Credit: Julia Koblitz/Unsplash. Give your business an edge with our leading industry insights. Thank you for subscribing View all newsletters from across the GlobalData Media network.

Packaging

Pharmaceutical Technology

JULY 15, 2025

Robert Barrie July 15, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook Hong Kong-listed Sino already owns a 4.91% stake courtesy of an investment in November 2024. Credit: Na_Studio via Shutterstock. Give your business an edge with our leading industry insights. Login Registration is disabled.

Packaging

Pharmaceutical Technology

JULY 15, 2025

Robert Barrie July 15, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook LEO calls Spevigo “the flagship dermatology product” of Boehringer Ingelheim. The deal is expected to close in the second half of 2025. Credit: JHVEPhoto via Shutterstock.

Packaging